Coastline Trust Co Has $21.74 Million Position in Eli Lilly and Company $LLY

robot
Abstract generation in progress

Coastline Trust Co significantly increased its stake in Eli Lilly and Company (LLY) by 12.0% in the fourth quarter, bringing its total holdings to 20,225 shares valued at $21.74 million. Other institutional investors like Vanguard Group Inc., State Street Corp, and Capital Research Global Investors also boosted their positions in LLY. The article highlights both positive sentiments (e.g., strong trial results for retatrutide and EBGLYSS, Jim Cramer’s endorsement) and negative sentiments (analyst downgrades, competitive pressures from Novo Nordisk) impacting Eli Lilly’s stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin